Nishio K - Search Results

1

Activation of HER family signaling as a mechanism of acquired resistance to ALK inhibitors in EML4-ALK-positive non-small cell lung cancer.

Tanizaki J, Okamoto I, Okabe T, Sakai K, Tanaka K, Hayashi H, Kaneda H, Takezawa K, Kuwata K, Yamaguchi H, Hatashita E, Nishio K, Nakagawa K. Tanizaki J, et al. Among authors: nishio k. Clin Cancer Res. 2012 Nov 15;18(22):6219-26. doi: 10.1158/1078-0432.CCR-12-0392. Epub 2012 Jul 27. Clin Cancer Res. 2012. PMID: 22843788

2

Mechanisms of collateral sensitivity to fluorouracil of a cis-diamminedichloroplatinum(II)-resistant human non-small lung cancer cell line.

Sugimoto Y, Ohe Y, Nishio K, Ohmori T, Morikage T, Fujiwara Y, Saijo N. Sugimoto Y, et al. Among authors: nishio k. Br J Cancer. 1992 Jun;65(6):857-64. doi: 10.1038/bjc.1992.181. Br J Cancer. 1992. PMID: 1319727 Free PMC article.

3

Mechanism of cross-resistance to a camptothecin analogue (CPT-11) in a human ovarian cancer cell line selected by cisplatin.

Niimi S, Nakagawa K, Sugimoto Y, Nishio K, Fujiwara Y, Yokoyama S, Terashima Y, Saijo N. Niimi S, et al. Among authors: nishio k. Cancer Res. 1992 Jan 15;52(2):328-33. Cancer Res. 1992. PMID: 1345810

4

Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin.

Kasahara K, Fujiwara Y, Nishio K, Ohmori T, Sugimoto Y, Komiya K, Matsuda T, Saijo N. Kasahara K, et al. Among authors: nishio k. Cancer Res. 1991 Jun 15;51(12):3237-42. Cancer Res. 1991. PMID: 1645616

5

Characterization of an etoposide-resistant human small-cell lung cancer cell line.

Minato K, Kanzawa F, Nishio K, Nakagawa K, Fujiwara Y, Saijo N. Minato K, et al. Among authors: nishio k. Cancer Chemother Pharmacol. 1990;26(5):313-7. doi: 10.1007/BF02897284. Cancer Chemother Pharmacol. 1990. PMID: 1976450

6

Resistance to anticancer drugs in NIH3T3 cells transfected with c-myc and/or c-H-ras genes.

Niimi S, Nakagawa K, Yokota J, Tsunokawa Y, Nishio K, Terashima Y, Shibuya M, Terada M, Saijo N. Niimi S, et al. Among authors: nishio k. Br J Cancer. 1991 Feb;63(2):237-41. doi: 10.1038/bjc.1991.56. Br J Cancer. 1991. PMID: 1997100 Free PMC article.

7

Cross-resistance to tumour promoters in human cancer cell lines resistant to adriamycin or cisplatin.

Nishio K, Sugimoto Y, Nakagawa K, Niimi S, Fujiwara Y, Bungo M, Kasahara K, Fujiki H, Saijo N. Nishio K, et al. Br J Cancer. 1990 Sep;62(3):415-9. doi: 10.1038/bjc.1990.309. Br J Cancer. 1990. PMID: 2206949 Free PMC article.

8

Antitumor activities of a new indolocarbazole substance, NB-506, and establishment of NB-506-resistant cell lines, SBC-3/NB.

Kanzawa F, Nishio K, Kubota N, Saijo N. Kanzawa F, et al. Among authors: nishio k. Cancer Res. 1995 Jul 1;55(13):2806-13. Cancer Res. 1995. PMID: 7796407

9

In vitro cytotoxicity of a novel antitumor antibiotic, spicamycin derivative, in human lung cancer cell lines.

Lee YS, Nishio K, Ogasawara H, Funayama Y, Ohira T, Saijo N. Lee YS, et al. Among authors: nishio k. Cancer Res. 1995 Mar 1;55(5):1075-9. Cancer Res. 1995. PMID: 7866991

10

Establishment of a human small-cell lung-cancer subline resistant to okadaic acid.

Takeda Y, Nishio K, Kubota N, Miura K, Morikage T, Ohmori T, Kudoh S, Niitani H, Saijo N. Takeda Y, et al. Among authors: nishio k. Int J Cancer. 1994 Sep 15;58(6):882-90. doi: 10.1002/ijc.2910580623. Int J Cancer. 1994. PMID: 7927883

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,209 results

Search Page

Filters